Neoadjuvant therapy of bevacizumab in combination with oxaliplatin and capecitabine (XELOX) for patients with metastatic colorectal cancer with unresectable liver metastases: a phase II, open‐label, single‐arm, noncomparative trial

By  

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 14, Iss. 1, 2018-02 ,pp. : 61-68

John Wiley & Sons Inc

Access to resources Recommend Favorite

A phase II trial of gefitinib in combination with capecitabine and oxaliplatin as first-line chemotherapy in patients with advanced colorectal cancer

By Gelibter Alain J.   Gamucci Teresa   Pollera Camillo F.   Di Costanzo Francesco   Nuzzo Carmen   Gabriele Angela   Signorelli Carlo   Gasperoni Silvia   Ferraresi Virginia   Giannarelli Diana   Cognetti Francesco   Zeuli Massimo  

Current Medical Research and Opinion, Vol. 23, Iss. 9, 2007-09 ,pp. : 2117-2123

Informa Healthcare

Access to resources Recommend Favorite

Oxaliplatin in Combination with Infusional 5-Fluorouracil and Leucovorin Every 2 Weeks as First-Line Treatment in Patients with Advanced Colorectal Cancer: A Phase II Study

By  

Oncology, Vol. 61, Iss. 1, 2001-07 ,pp. : 36-41

Karger

Access to resources Recommend Favorite

Docetaxel plus Oxaliplatin in Combination with Capecitabine as First-Line Treatment for Advanced Gastric Cancer

By  

Oncology, Vol. 80, Iss. 5-6, 2011-07 ,pp. : 359-365

Karger

Access to resources Recommend Favorite

Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy

By  

Oncology, Vol. 90, Iss. 1, 2016-0 ,pp. : 36-42

Karger

Access to resources Recommend Favorite